Earnings resilience and strong operating leverage make Avalo Therapeutics, Inc. (AVTX) a compelling risk/reward at current valuations. Watching margin guidance closely.
♥ 0 Thanks from members
Posted 2/15/2026
Earnings resilience and strong operating leverage make Avalo Therapeutics, Inc. (AVTX) a compelling risk/reward at current valuations. Watching margin guidance closely.